Loading company…
Solid IO develops organ-on-chip technology for cancer treatment research and precision oncology.
Solid IO develops a tumor-on-chip platform that models patient tumor environments and provides insights into responses to immuno-oncology treatments. It serves pharmaceutical companies, biotech firms, and cancer clinics. Founded in 2025 in Helsinki, Finland, the company raised EUR 800,000 in February 2025, led by Nordic Science Investments with participation from Baltic Sandbox Ventures and Helsinki University Funds.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in